Asian Journal of Transfusion Science

CASE REPORT
Year
: 2022  |  Volume : 16  |  Issue : 1  |  Page : 140--143

Effect of cryoprecipitate transfusion without ABO group consideration: A nightmare experience


Dibyajyoti Sahoo, Pragya Silwal 
 Department of Transfusion Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India

Correspondence Address:
Dibyajyoti Sahoo
Department of Transfusion Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry - 605 006
India

The cryoprecipitate is an essential blood product as they are rich in factor VIII, fibrinogen, von Willebrand factor, factor XIII, and fibronectin, and their volume is too small. They play a significant role in the management of massive transfusion nowadays. Usually, they are used without ABO group consideration. We here report a case in which immunohematological problems arose due to out-of-group transfusion of cryoprecipitate. We suggest that the possibility of incompatibility subsequently is to be kept in mind during transfusion of large quantity cryoprecipitate, and ABO group compatible may be preferred.


How to cite this article:
Sahoo D, Silwal P. Effect of cryoprecipitate transfusion without ABO group consideration: A nightmare experience.Asian J Transfus Sci 2022;16:140-143


How to cite this URL:
Sahoo D, Silwal P. Effect of cryoprecipitate transfusion without ABO group consideration: A nightmare experience. Asian J Transfus Sci [serial online] 2022 [cited 2022 Oct 6 ];16:140-143
Available from: https://www.ajts.org/article.asp?issn=0973-6247;year=2022;volume=16;issue=1;spage=140;epage=143;aulast=Sahoo;type=0